Results 171 to 180 of about 2,974 (211)
Some of the next articles are maybe not open access.
Effect and mechanism of oritavancin on hIAPP amyloid formation
Journal of Materials Chemistry BThe binding of oritavancin to hIAPP suppresses hIAPP amyloidosis, thereby alleviating the resultant oxidative damage and apoptosis of cells.
Sheng-Nan Wang +6 more
openaire +2 more sources
Current opinion in investigational drugs (London, England : 2000), 2002
Oritavancin (LY-333328), a lead glycopeptide from a series targeted at vancomycin-resistant bacteria, especially enterococci, is under development by Eli Lilly for the potential treatment of bacterial infections. It entered phase III trials in the US in January 2001 [396223] and the company expects to submit an NDA by 2003 [396478].
openaire +1 more source
Oritavancin (LY-333328), a lead glycopeptide from a series targeted at vancomycin-resistant bacteria, especially enterococci, is under development by Eli Lilly for the potential treatment of bacterial infections. It entered phase III trials in the US in January 2001 [396223] and the company expects to submit an NDA by 2003 [396478].
openaire +1 more source
Oritavancin and Tigecycline: Investigational Antimicrobials for Multidrug‐Resistant Bacteria
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2004The advent of multidrug‐resistant gram‐positive aerobes such as Staphylococcus aureus, Streptococcus pneumoniae , and the enterococci, which are resistant to β‐lactams, vancomycin, and a host of other commonly used antimicrobials, has complicated our approach to antibiotic therapy.
openaire +2 more sources
Parametri di esplosività di polveri Oritavancin
2012Il Lavoro ha comportato la misura ai fini della sicurezza di processo dei valori dei parametri di Esplosione e di Infiammabilità (Minimum Ignition Temperature e Minimum Ignition Energy) relativi a polveri di ...
Roberto Sanchirico, Andrea Bizzarro
openaire +1 more source